Is High Homocysteine Really Worth Treating?
High homocysteine has been associated with several medical conditions, including cardiovascular disease, stroke, cognitive decline, brain atrophy, and an increased risk of bone fractures. However, does correcting an elevated homocysteine level necessarily protect you from these conditions?
Homocysteine is an amino acid produced during the metabolism of methionine. Maintaining normal homocysteine levels depends partly on an adequate supply of vitamin B12, folate, and vitamin B6. Elevated levels may also result from kidney disease, hypothyroidism, certain medications, and genetic abnormalities.
Despite the strong association between high homocysteine and cardiovascular disease, large clinical studies have produced unexpected results. Although B-vitamin supplementation effectively lowers homocysteine, it has not demonstrated significant benefits in reducing heart attacks or overall mortality. The evidence concerning stroke prevention, however, is somewhat more encouraging.
One particularly intriguing area of research concerns brain health. Scientists at the University of Oxford discovered that B-vitamin supplementation slowed brain atrophy in certain older adults with mild cognitive impairment. The benefits were particularly pronounced among participants with higher homocysteine levels. However, these findings do not establish that vitamin supplementation prevents dementia.
In this episode of Candid Conversations with Dr. Lowe, we examine the scientific evidence surrounding high homocysteine and explore whether lowering this blood marker is a worthwhile therapeutic objective.
More importantly, we consider why identifying the underlying cause of elevated homocysteine may be more clinically valuable than simply attempting to normalize the laboratory result.
Watch the accompanying video to discover what your homocysteine blood test may reveal about your health and why you should discuss an elevated result with your physician:
Scientific References
Homocysteine-lowering interventions for preventing cardiovascular events. Cochrane Database of Systematic Reviews (2017).https://pmc.ncbi.nlm.nih.gov/articles/PMC6483699/
Homocysteine lowering with folic acid and B vitamins in vascular disease. New England Journal of Medicine (2006).https://pubmed.ncbi.nlm.nih.gov/16531613/
Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment. PLOS ONE (2010).https://pmc.ncbi.nlm.nih.gov/articles/PMC2935890/
Effects of homocysteine lowering with B vitamins on cognitive aging: Meta-analysis of 11 trials involving approximately 22,000 individuals (2014).https://pmc.ncbi.nlm.nih.gov/articles/PMC4095663/
B-vitamin supplementation and bone health: A systematic review and meta-analysis of randomized controlled trials (2024).https://pubmed.ncbi.nlm.nih.gov/38953947/
Medical Disclaimer: This publication is intended for educational purposes and is not a substitute for individualized medical advice, diagnosis, or treatment.



Comments